Related Experiment Video
Updated: Jun 9, 2025

Culture of Neurospheres Derived from the Neurogenic Niches in Adult Prairie Voles
Published on: June 10, 2020
Oxytocin in neurodevelopmental disorders: Autism spectrum disorder and Prader-Willi syndrome
Alyssa Josselsohn1, Yin Zhao2, Danielle Espinoza3
1Albert Einstein College of Medicine, Montefiore Medical Center, 1225 Morris Park Avenue Bronx, NY 10461, USA; Temple University, College of Education and Human Development, 1301 Cecil B. Moore Ave, Philadelphia, PA 19122, USA.
Insights
Oxytocin shows mixed results for treating neurodevelopmental disorders like autism spectrum disorder (ASD) and Prader-Willi syndrome (PWS). Dynamic dosing and social interventions may improve oxytocin
Area of Science:
- Neurobiology
- Pharmacology
- Developmental Psychology
Background:
- Oxytocin plays a crucial role in social behaviors, bonding, and appetite regulation.
- Dysfunction in the oxytocin system is implicated in the pathophysiology of autism spectrum disorder (ASD) and Prader-Willi syndrome (PWS).
Purpose of the Study:
- To review current research on oxytocin's efficacy in treating core symptoms of ASD and PWS.
- To examine oxytocin's clinical pharmacology, safety, and trial outcomes.
- To propose optimized therapeutic strategies for oxytocin intervention.
Main Methods:
- Systematic review of recent clinical trials and pharmacological studies on oxytocin.
- Analysis of oxytocin's effects on social behaviors, anxiety, and feeding in neurodevelopmental disorders.
Main Results:
- Clinical trials investigating oxytocin for ASD and PWS have yielded inconsistent results.
- Oxytocin's effectiveness appears variable, necessitating further investigation into optimal dosing and delivery.
Conclusions:
- Oxytocin's therapeutic potential for ASD and PWS requires refined application strategies.
- A dynamic (as-needed) dosing regimen, combined with social interventions, may enhance oxytocin's benefits in these populations.
Abstract:
This manuscript reviews recent work on oxytocin and its use in neurodevelopmental disorders including spectrum disorder (ASD) and Prader-Willi syndrome (PWS). Oxytocin is involved in social recognition, bonding, maternal behaviors, anxiety, food motivation, and hyperphagia. While the pathophysiology of ASD and PWS involve abnormalities in the oxytocin system, clinical trials have shown discrepant results in the effectiveness of oxytocin as a treatment for core symptoms associated with these disorders. In this review, we outline oxytocin's clinical pharmacology, safety considerations, and results in recent clinical trials. We propose that oxytocin may be most beneficial in these populations if dosed in a dynamic regimen (PRN) and paired with social interventions.
Related Concept Videos
Neurotransmitters
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Operant Conditioning Intervention
In operant conditioning, behaviors that are...
Oppositional Defiant Disorder
Diagnostic Criteria and...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....

